Moderately bullish activity in Pfizer (PFE), with shares up 4c, or 0.14%, near $25.23. Options volume relatively light with 116k contracts traded and calls leading puts for a put/call ratio of 0.38, compared to a typical level near 0.5. Implied volatility (IV30) dropped 1.43 near 18.96,in the lowest 10% of observations over the past year, suggesting an expected daily move of $0.30. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Government deals lift overhang on pharma group, says BofA
- JPMorgan Quants Identify 6 Stocks at Risk of a Sharp Reversal
- Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports
- Pfizer’s New Liver Cancer Trial Signals a Longer-Term Oncology Upside for PFE
- Salesforce’s Agentforce Life Sciences Gains Traction with Another Healthcare Provider Onboard